Home
Contact Us
facebook
twitter
linkedin
menu
Menu
About Us
Show sub menu
arrow-down
Mission
Members
Board of Directors
Staff
COVID-19
Economic Impact
Issues
Show sub menu
arrow-down
Laboratory Innovation & Operations
Saving Access to Lab Services
Regulatory Issues
Reimbursement & Coverage
Value of Clinical Labs
Take Action
Newsroom
Show sub menu
arrow-down
ACLA Blog
ACLA Press Releases
Comments and Letters
Spotlight on Lab Professionals
All News
Member Resources
Show sub menu
arrow-down
ACLA Member SALSA Act Toolkit
CPT Committee
Prior Authorization Work Group
Join Us
Close Menu
cross
Home
Contact Us
About Us
Show sub menu
arrow-down
Mission
Members
Board of Directors
Staff
COVID-19
Economic Impact
Issues
Show sub menu
arrow-down
Laboratory Innovation & Operations
Saving Access to Lab Services
Regulatory Issues
Reimbursement & Coverage
Value of Clinical Labs
Take Action
Newsroom
Show sub menu
arrow-down
ACLA Blog
ACLA Press Releases
Comments and Letters
Spotlight on Lab Professionals
All News
Member Resources
Show sub menu
arrow-down
ACLA Member SALSA Act Toolkit
CPT Committee
Prior Authorization Work Group
Join Us
Home
|
All News
|
Comments and Letters
|
ACLA Comments on Novitas DL34914, Assays of Vitamins and Metabolic Function
ACLA Comments on Novitas DL34914, Assays of Vitamins and Metabolic Function
March 10, 2016
Categories:
Comments and Letters
,
Issues
,
All News
,
Reimbursement and Coverage
Download (PDF, 161KB)
Print page / Save as PDF
